Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia

類似資料

• Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemiass
  著者:: Jianmei Xu, 等
  出版事項: (2025-03-01)
• Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients
  著者:: Pierre Peterlin, 等
  出版事項: (2023-11-01)
• Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
  著者:: Yifan Zhao, 等
  出版事項: (2024-10-01)
• Case report: Successful combination of CLL1 CAR-T therapy and hematopoietic stem cell transplantation in a 73-year-old patient diagnosed with refractory acute myeloid leukemia
  著者:: Yifan Zhao, 等
  出版事項: (2024-09-01)
• Efficacy analysis of iptacopan in a patient with thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: a case report
  著者:: Zixuan Zhao, 等
  出版事項: (2026-03-01)